2009
DOI: 10.1186/1475-2875-8-176
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in urban health facilities in Yaoundé, central province, Cameroon

Abstract: Background: After adoption of artesunate-amodiaquine (AS/AQ) as first-line therapy for the treatment of uncomplicated malaria by the malaria control programme, this study was designed to assess the availability of anti-malarial drugs, treatment practices and acceptability of the new protocol by health professionals, in the urban health facilities and drugstores of Yaoundé city, Cameroon.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
42
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(46 citation statements)
references
References 9 publications
(8 reference statements)
3
42
0
Order By: Relevance
“…[25] This promotes drug resistance [2] and reduces the proportion of patients receiving appropriate treatment, especially when stock is in short supply. [26] Substandard, counterfeit and self-medication pose challenges to malaria interventions in Cameroon. [27,28,29] Poor legislation led to the influx of 32%, 10% and 13% of substandard and cheap chloroquine, quinine and sulphadoxine pyrimethamine respectively into Cameroon, [28] including ACT used as recommended first-line treatment of uncomplicated malaria.…”
Section: Case Managementmentioning
confidence: 99%
“…[25] This promotes drug resistance [2] and reduces the proportion of patients receiving appropriate treatment, especially when stock is in short supply. [26] Substandard, counterfeit and self-medication pose challenges to malaria interventions in Cameroon. [27,28,29] Poor legislation led to the influx of 32%, 10% and 13% of substandard and cheap chloroquine, quinine and sulphadoxine pyrimethamine respectively into Cameroon, [28] including ACT used as recommended first-line treatment of uncomplicated malaria.…”
Section: Case Managementmentioning
confidence: 99%
“…Furthermore, lumefantrine, widely prescribed in Africa with artemether, is well known to also select the pfmdr1 genotype leading to a lesser susceptibility to aryl amino alcohols (7,22). Added to this, the prevalence of pfmdr1 amplification may be increased by some combined formulations, such as MQ plus artesunate and MQ plus sulfadoxinepyrimethamine, used in several African countries although not supported by official health policies (14,20). The global switch from CQ to aryl amino alcohol-based ACTs would be a critical conjunction for the emergence of clones with drug resistance related to the pfmdr1 genotype.…”
Section: Case Reportmentioning
confidence: 99%
“…In sub Saharan Africa, 80% of children less than five years old die from malaria [6,7]. In Cameroon, malaria accounts for 30% of all morbidity cases, 36% of outpatient consultations, 67% of childhood deaths and 48% of all hospital admissions [8,9].…”
Section: Introductionmentioning
confidence: 99%